No Data
No Data
Shengxiang Biology (688289): Demand for respiratory products increased, revenue from conventional reagents doubled in 2023
Incident: The company released its 2023 annual report and 2024 quarterly report. In 2023, it achieved revenue of 1.007 billion yuan (yoy -84.39%) and net profit to mother of 364 million yuan (yoy-81.
Sansure Biotech Inc.'s (SHSE:688289) Shares May Have Run Too Fast Too Soon
Sansure Biotech Inc.'s (SHSE:688289) price-to-sales (or "P/S") ratio of 10.8x might make it look like a strong sell right now compared to the Medical Equipment industry in China, where around half of
Shengxiang Biotech (688289.SH): Net profit of 81.025 million yuan in the first quarter increased 35.01% year-on-year
On April 26, Ge Longhui (688289.SH) released its report for the first quarter of 2024, achieving operating income of 391 million yuan, an increase of 100.31%; net profit attributable to shareholders of listed companies of 81.025 million yuan, an increase of 35.01% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 73.755 million yuan, an increase of 1962.06% year on year; basic earnings per share of 0.14 yuan.
Express News | Shengxiang Biotech: Net profit forecast to increase 35.79% in the first quarter of 2024
Sansure Biotech (SHSE:688289) Could Easily Take On More Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi
Shengxiang Biology (688289): The performance report is in line with expectations, leading molecular diagnostics companies are growing rapidly
Core view In the short term, with the significant increase in domestic PCR production capacity, testing efficiency and clinical awareness, the molecular diagnosis penetration rate is expected to increase rapidly. As an industry leader, the company is expected to achieve rapid development in the fields of respiratory, maternal and child, and blood screening
No Data